Literature DB >> 10657018

Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma.

L Dubuisson1, A Monvoisin, B S Nielsen, B Le Bail, P Bioulac-Sage, J Rosenbaum.   

Abstract

The urokinase-type plasminogen activator (uPA) and its receptor (uPAR) play an important role in tumour invasion. Previous studies have shown by RT-PCR that uPA and uPAR mRNAs are expressed in human hepatocellular carcinoma (HCC). Here, in situ hybridization, immunohistochemistry, and double immunofluorescence were used to identify the cells expressing uPA and uPAR in 26 HCCs. The results indicate that uPA and uPAR were expressed in every case, almost exclusively in stromal cells, mostly myofibroblasts and macrophages, except for rare tumoural hepatocytes expressing cytokeratin 7. These results show the important role of stromal cells of HCC in the pericellular proteolysis which facilitates cancer cell invasion. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657018     DOI: 10.1002/(SICI)1096-9896(200002)190:2<190::AID-PATH511>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

1.  Stellate cells in the digestive tract.

Authors:  Hendrik Reynaert; Filip Sermon; Daniel Urbain; Albert Geerts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

2.  Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR.

Authors:  Junwei Hou; Xin Li; Changfei Li; Lu Sun; Yulai Zhao; Jingmin Zhao; Songdong Meng
Journal:  Mol Oncol       Date:  2015-03-24       Impact factor: 6.603

3.  Proteinases and their inhibitors in liver cancer.

Authors:  Verena Puxbaum; Lukas Mach
Journal:  World J Hepatol       Date:  2009-10-31

4.  Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical.

Authors:  Eduardo Rodrigues Fregnani; Lays M Sobral; Fabio Abreu Alves; Fernando Augusto Soares; Luis Paulo Kowalski; Ricardo D Coletta
Journal:  Pathol Oncol Res       Date:  2008-12-19       Impact factor: 3.201

5.  Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases.

Authors:  Y Kita; T Fukagawa; K Mimori; Y Kosaka; K Ishikawa; T Aikou; S Natsugoe; M Sasako; M Mori
Journal:  Br J Cancer       Date:  2008-12-02       Impact factor: 7.640

6.  New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis.

Authors:  S Sagmeister; M Eisenbauer; C Pirker; T Mohr; K Holzmann; H Zwickl; C Bichler; D Kandioler; F Wrba; W Mikulits; C Gerner; M Shehata; O Majdic; B Streubel; W Berger; M Micksche; K Zatloukal; R Schulte-Hermann; B Grasl-Kraupp
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

Review 7.  Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.

Authors:  Bing-Tao Zhai; Huan Tian; Jing Sun; Jun-Bo Zou; Xiao-Fei Zhang; Jiang-Xue Cheng; Ya-Jun Shi; Yu Fan; Dong-Yan Guo
Journal:  J Transl Med       Date:  2022-03-18       Impact factor: 5.531

Review 8.  The role of the myofibroblast in tumor stroma remodeling.

Authors:  Marcela Otranto; Vincent Sarrazy; Frédéric Bonté; Boris Hinz; Giulio Gabbiani; Alexis Desmoulière
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

Review 9.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

Authors:  Niaz Mahmood; Catalin Mihalcioiu; Shafaat A Rabbani
Journal:  Front Oncol       Date:  2018-02-12       Impact factor: 6.244

10.  Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis.

Authors:  Pengxian Tao; Lei Gao; Haiyuan Li; Bofang Wang; Xuemei Li; Ying Zhang; Hao Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.